Volume 35 Number 9 August 27 - September 3, 2015
Ethics, Policy and Law
An unfulfilled promise: Changes needed to the drug approval process to make personalized medicine a reality.
Riley MF et al. Food Drug Law J 2015 70(2) 289-314, ii-iii
Riley MF et al. Food Drug Law J 2015 70(2) 289-314, ii-iii
Ethical considerations in presymptomatic diagnosis of autosomal dominant spinocerebellar ataxias.
Orozco-Gutiérrez MH et al. Neurologia 2015 Aug 21.
Orozco-Gutiérrez MH et al. Neurologia 2015 Aug 21.
Military health care dilemmas and genetic discrimination: A family's experience with whole exome sequencing.
Helm BM et al. Narrat Inq Bioeth 2015 5(2) 179-86
Helm BM et al. Narrat Inq Bioeth 2015 5(2) 179-86
Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil.
Santos RV et al. Biosocieties 2015 Mar 1. 10(1) 48-69
Santos RV et al. Biosocieties 2015 Mar 1. 10(1) 48-69
The gene patent controversy on Twitter: a case study of Twitter users' responses to the CHEO lawsuit against Long QT gene patents.
Du Li et al. BMC Med Ethics 2015 1655
Du Li et al. BMC Med Ethics 2015 1655
The limits of FDA's authority to regulate clinical research involving high-throughput DNA sequencing.
Evans BJ et al. Food Drug Law J 2015 70(2) 259-87, ii
Evans BJ et al. Food Drug Law J 2015 70(2) 259-87, ii
.png)
No hay comentarios:
Publicar un comentario